Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of Advanced Cell Diagnostics (ACD), a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The transaction closed on August 1, 2016.

Fredrikson’s legal team was led by Ryan Brauer, Zach Olson and Sarah Tucher.

Read the news release.

Jump to Page

Fredrikson & Byron, P.A. stores cookies on your device to enhance site navigation, make your browsing experience as useful as possible, and analyze site usage. By accessing this website with cookies enabled in your web browser, you agree to the storing of cookies on your device. Please read our Privacy Policy and our Disclaimer.